Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Interferon gamma-1b by Amgen for Relapsed Acute Myeloid Leukemia: Likelihood of Approval
Interferon gamma-1b is under clinical development by Amgen and currently in Phase II for Relapsed Acute Myeloid Leukemia. According to...
Data Insights
Interferon gamma-1b by Amgen for Myelodysplastic Syndrome: Likelihood of Approval
Interferon gamma-1b is under clinical development by Amgen and currently in Phase II for Myelodysplastic Syndrome. According to GlobalData, Phase...